EntryPoint Capital’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
CC
EntryPoint Capital's PRCT Position: Q2 2026 in Review
EntryPoint Capital opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 14,359 shares worth $324K. The stake represents 0.08% of the portfolio and ranks #514 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in PRCT as recently as Q2 2025.
EntryPoint Capital first reported a position in PRCT in Q4 2023 and has held it in 8 quarters since. The position peaked at $469K in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.
- EntryPoint Capital held 14,359 shares of Procept Biorobotics worth $324K as of Q2 2026.
- Procept Biorobotics was a new EntryPoint Capital position in Q2 2026.
- Procept Biorobotics made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #514 holding.
- EntryPoint Capital first reported a position in Procept Biorobotics in Q4 2023 and has held it in 8 quarters since.
- EntryPoint Capital's Procept Biorobotics position peaked at $469K in Q3 2024.
- 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.